news-details
Health,Health Technology,Health Services,Watchlist

1 HealthTech Stocks up over 84% past 10 days (BEAT stock, LVTX stock)

Today, the screeners at HealthTechMovers.com picked up 2 HealthTech Stocks up over 84% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.

One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com. 

 

HeartBeam, BEAT
Summary: HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.
Recent BEAT Stock Price (approx 10:00am EST.): $2.85
Previous Close for BEAT Stock: $2.69
Percentage Price Change Past 10 Days for BEAT stock: +115% 

TipRanks.com reports that HeartBeam stock currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for BEAT stock with an average price target is $12.00. 

Click here to get the full story on BEAT stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

LAVA Therapeutics, LVTX
Summary: LAVA Therapeutics B.V. is a biotechnology company. It focuses on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy. LAVA Therapeutics B.V. is based in UTRECHT, The Netherlands.
Recent LVTX Stock Price (approx 10:00am EST.): $4.69
Previous Close for LVTX Stock: $4.74
Percentage Price Change Past 10 Days for LVTX stock: +84% 

TipRanks.com reports that LAVA Therapeutics stock currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating for LVTX stock with an average price target is $17.33. 

Click here to get the full story on LVTX stock >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------


Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com.

The other great tool for charting is TradingView.com, so you might want to check that out too.

The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.

FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.